TGF beta 2 mRNA expression and pregnancy failure in mice

Area of Science:

• Reproductive immunology
• Developmental biology
• Molecular genetics

Background:

• Pregnancy loss is a significant concern in reproductive health.
• Transforming growth factor (TGF) beta2 plays a role in fetal-maternal interactions.
• Understanding TGF beta2 expression patterns is crucial for identifying mechanisms of pregnancy failure.

Purpose of the Study:

• To investigate the expression pattern of TGF beta2 mRNA at the fetomaternal interface in mice with high rates of resorption.
• To examine the effect of maternal immunopotentiation on TGF beta2 mRNA expression in the context of pregnancy loss.

Main Methods:

• TGF beta2 mRNA expression was quantified using RNase protection assay in uteroplacental units of mice with spontaneous or cyclophosphamide (CP)-induced pregnancy loss.
• In situ hybridization was employed to study the distribution of TGF beta2 mRNA transcripts.
• The impact of nonspecific immunostimulation with xenogeneic leukocytes on TGF beta2 mRNA was assessed in CP-treated mice.

Main Results:

• A significant decrease (approximately 50%) in TGF beta2 mRNA levels was observed in mice with pregnancy loss compared to controls.
• TGF beta2 mRNA expression was reduced in metrial gland cells of CP-treated mice and lost in uterine epithelium of resorbing units.
• Maternal immunopotentiation reduced resorption rates and dramatically increased TGF beta2 mRNA expression (2.0-3.2 fold) in CP-treated mice.

Conclusions:

• Altered TGF beta2 expression at the fetomaternal interface is associated with pregnancy failure.
• Maternal immunostimulation's beneficial effect may be partly mediated by a significant increase in TGF beta2 mRNA expression.
• TGF beta2 is implicated as a key factor in maintaining successful pregnancy and may be a target for therapeutic interventions.